Mapping large numbers of results may take a few moments.
Search Results
Showing 1 - 50 of 57 results found.
Company | Activity | Company Description | Location | |
---|---|---|---|---|
Company BD Technologies and Innovation (RTP) | Activity: Research and Development | Company Description BD is a global medical technology company working to improve medical discovery, diagnostics and the delivery of care. The RTP site, established in 1972, is the North American hub of BD's global enterprise R&D network. | Location Research Triangle Park | |
Company 3i-Nano | Activity: Research and Development | Company Description 3i Nano develops point-of-care devices for disease diagnostics and protein detection. Potential applications include cardiac, sepsis, meningitis, and respiratory. | Location Greensboro | |
Company AccuNovo Biotechnologies Inc. | Activity: Research and Development | Company Description Accunovo is developing novel targeted PET imaging probes through a combination of unique biomarker-binding molecules and imaging-guided precision radiopharmaceuticals for solid tumors. | Location Chapel Hill | |
Company Ad Astra Diagnostics Inc. | Activity: Research and Development | Company Description Ad Astra Diagnostics develops rapid human health diagnostics and data systems. | Location Morrisville | |
Company Advanced Animal Diagnostics Inc. | Activity: Research and Development | Company Description Advanced Animal Diagnostics (AAD) develops and commercializes diagnostics to detect and manage disease states, reproductive, nutritional and overall health status of production animals. | Location Morrisville | |
Company Aestas Pharma Inc. | Activity: Research and Development | Company Description Aestas Pharma develops novel diagnostic imaging and disease-modifying therapeutic agents to enable the detection, early treatment and reversal of Alzheimer’s disease when clinical signs are not yet pronounced. | Location Durham | |
Company Affinergy LLC | Activity: Research and Development | Company Description Affinergy develops diagnostic tools for rare and difficult to diagnose diseases. Affinergy's development programs include rapid assays for proteins, drugs, cells and small molecules. | Location Durham | |
Company Appealing Products Inc. | Activity: Research and Development | Company Description Appealing Products develops products for forensics and personal protection from toxic materials such as inorganics, gases and poisons in foods, animal feeds and liquids. | Location Raleigh | |
Company Arcus-Med LLC | Activity: Research and Development | Company Description Arcus-Med is developing software to diagnose pulmonary hypertension (PH). | Location Raleigh | |
Company Atom Bioworks Inc. | Activity: Research and Development | Company Description Atom Bioworks has developed a platform for programming DNA/RNA-based biomolecules as high-affinity binding reagents. | Location Cary | |
Company Biofidelity Inc. | Activity: Research and Development | Company Description Biofidelity provides simple, high-sensitivity diagnostic assays which enable patient monitoring and precision medicine. | Location Morrisville | |
Company BioMedomics Inc. | Activity: Research and Development | Company Description BioMedomics develops and manufactures point-of-care (POC) diagnostics in hematology oncology, virology, women’s health and dermatology. | Location Morrisville | |
Company Bloodless Dx LLC | Activity: Research and Development | Company Description Bloodless Dx is an assay development company focused on bloodless diagnostics. | Location Apex | |
Company Cellex Inc. | Activity: Research and Development | Company Description Cellex develops, manufactures and markets diagnostic tests suitable for point-of-care use. These tests use a platform technology called Homogeneous Biochemiluminescence Assay (HBA), which enables assays that are highly sensitive and easy-to-use. | Location Cary | |
Company CellSolutions LLC | Activity: Research and Development | Company Description CellSolutions develops liquid-based preparation and evaluation systems for cytology applications. The company's primary area of focus is women's health, including cervical cancer screening, precancer detection and evaluation of infectious disease. | Location Greensboro | |
Company Countervail Corp. | Activity: Research and Development | Company Description Countervail is developing proprietary drug and diagnostic technologies to detect exposure to and prevent adverse effects from organophosphate pesticides. | Location Mint Hill | |
Company Datar Cancer Genetics | Activity: Research and Development | Company Description Datar Cancer Genetics develops blood-based diagnostics for early cancer detection and identifies personalized treatment strategies based on genomic and cellular analysis of a patient's cancer. | Location Morrisville | |
Company Diabetic Health Inc. | Activity: Research and Development | Company Description Diabetic Health develops coatings to improve the longevity and performance of continuous glucose monitoring sensors (CGM) and insulin infusion sets used in diabetes management. | Location Research Triangle Park | |
Company Domus Diagnostics | Activity: Research and Development | Company Description Domus Diagnostics is a point-of-care diagnostics company that develops accurate, rapid molecular tests for infectious diseases. | Location Durham | |
Company Endacea Diagnostics Inc. | Activity: Research and Development | Company Description Endacea Diagnostics is developing EndaTox IVD, an in vitro sepsis diagnostic, and EndaTox Test, an assay to measure LPS endotoxin in biological and non-biological samples. | Location Research Triangle Park | |
Company Endacea Inc. | Activity: Research and Development | Company Description Endacea develops A1 adenosine receptor antagonists as drug candidates for cancer, COVID-19 acute lung injury, sepsis and acute renal failure. | Location Research Triangle Park | |
Company Entegrion Inc. | Activity: Research and Development | Company Description Entegrion offers a novel point of care in vitro diagnostic blood coagulation monitoring system for use in human and veterinary medicine. | Location Durham | |
Company EydisBio Inc. | Activity: Research and Development | Company Description Eydis Bio is developing a platform of small molecule therapeutics targeting a variety of diseases driven by aberrant inflammatory/autoimmune processes. | Location Durham | |
Company Foundation Medicine Inc. | Activity: Research and Development | Company Description Foundation Medicine develops and provides clinical assays that provide a comprehensive genomic profile to identify molecular alterations in a patient's cancer and match them with targeted therapies and clinical trials. | Location Morrisville | |
Company Gemelli Biotech | Activity: Sales and Operations | Company Description Gemelli Biotech develops diagnostics and therapeutics for microbiome diseases. | Location Raleigh | |
Company GeneCentric Therapeutics Inc. | Activity: Research and Development | Company Description GeneCentric Therapeutics develops molecular diagnostic assays to enable oncologists and their patients to make informed, individualized treatment decisions. | Location Research Triangle Park | |
Company GeneType | Activity: Research and Development | Company Description GeneType develops genetic risk assessment tests to predict an individual's risk of developing chronic disease. | Location Charlotte | |
Company HemoSonics LLC | Activity: Research and Development | Company Description HemoSonics is developing an in vitro diagnostic platform that measures the evolving stiffness of forming blood clots within a consumable test cartridge. Its technology assists with the management of coagulation dysfunctions at the point of care. | Location Durham | |
Company HIPRA Scientific USA LLC | Activity: Research and Development | Company Description Hipra researches and develops vaccines, diagnostics and pharmaceuticals for animal health. | Location Raleigh | |
Company Inanovate Inc. | Activity: Research and Development | Company Description Inanovate has developed a patented blood analysis system (the Bio-ID) for diagnostic tests. The first application of the Bio-ID is a new blood test to detect breast cancer recurrence at a stage when it may still be cured. | Location Chapel Hill | |
Company Inivata Inc. | Activity: Research and Development | Company Description Inivata develops a noninvasive liquid biopsy diagnostic using the precision of circulating tumor DNA (ctDNA) analysis for improving cancer detection and assessing individual response to treatment. | Location Research Triangle Park | |
Company Jericho Sciences LLC | Activity: Research and Development | Company Description Jericho Sciences is developing antiviral therapeutics and corresponding personalized diagnostic assays which specifically address the limitations of current combination antiretroviral therapy (cART) in the clinical management of HIV-1 infection to reduce underlying sources of persistent virus. | Location Durham | |
Company Kalia Health | Activity: Research and Development | Company Description Kalia Health develops home-based early detection tests for pregnancy complications like preeclampsia and eclampsia for use in low-resource settings. | Location Chapel Hill | |
Company Lucerno Dynamics LLC | Activity: Research and Development | Company Description Lucerno Dynamics is commercializing a medical device for quality control, dosimetry, and quality assurance for nuclear medicine. Future applications of the technology include rheumatoid arthritis, immunotherapy, and chemotherapy assessment. | Location Cary | |
Company MDxHealth Inc. | Activity: Research and Development | Company Description MDxHealth develops epigenetic technologies to personalize the diagnosis and treatment of cancer. | Location Hillsborough | |
Company MIDAS Biotech LLC | Activity: Research and Development | Company Description MIDAS Biotech develops in vitro diagnostic products. | Location Morrisville | |
Company MultiSeq Inc. | Activity: Research and Development | Company Description MultiSeq out-licenses molecular diagnostics platform technologies for cancer and infectious disease diagnosis. | Location Greensboro | |
Company NanoDiagnostic Technology LLC | Activity: Research and Development | Company Description Nanodiagnostic Technology develops nanotechnology-based portable analytical devices for onsite rapid and sensitive detection of toxic chemical exposure, SARs-COV-2, and diseases at the point of care. | Location Kannapolis | |
Company New Hope Biodiagnostics LLC | Activity: Research and Development | Company Description New Hope Biodiagnostics is developing biodiagnostics for cancer. | Location Chapel Hill | |
Company NIOX Group | Activity: Sales and Operations | Company Description NIOX is a diagnostics and management company focused on improving asthma diagnosis and management. | Location Morrisville | |
Company NIRvana Sciences Inc. | Activity: Research and Development | Company Description NIRvana Sciences is commercializing red and near-infrared fluorescent dyes for use in diagnostics and imaging applications. | Location Research Triangle Park | |
Company OncoTAb Inc. | Activity: Research and Development | Company Description OncoTAb develops a continuum of products from early detection to treatment of epithelial cancers. Current products on the market and under development address unmet needs in the detection and treatment of pancreatic cancer as well as triple negative and metastatic breast cancer. | Location Charlotte | |
Company OrangeBiomed Inc. | Activity: Sales and Operations | Company Description Orange Biomed is a healthcare startup developing diabetes management technology. | Location Hillsborough | |
Company Path BioAnalytics Inc. | Activity: Research and Development | Company Description Path BioAnalytics (PBA) is a precision medicine company dedicated to the advancement of next-generation of treatments for individuals living with respiratory disease. | Location Durham | |
Company Phenogen Sciences Inc. | Activity: Sales and Operations | Company Description Phenogen Sciences provides predictive testing and risk assessment tools that help physicians proactively manage patient health. | Location Charlotte | |
Company Precision Diabetes Inc. | Activity: Sales and Operations | Company Description Precision Diabetes is developing a spectrum of unique diabetes tests, from detecting the risk of developing diabetes to diagnosing complications from diabetes. | Location Cary | |
Company Resonantia Diagnostics | Activity: Research and Development | Company Description Resonantia Diagnostics is a startup developing a point of care diagnostic platform that rapidly identifies a pathogen from a clinical specimen and determines the pathogen's antimicrobial susceptibility. | Location Durham | |
Company Revvity | Activity: Research and Development | Company Description Revvity provides health science solutions, technologies, expertise and services that deliver complete workflows from discovery to development. | Location Durham | |
Company Salvus LLC | Activity: Research and Development | Company Description Salvus provides a handheld chemical and biological interferometric detector, a device which has the ability to rapidly identify chemicals, pathogens and viruses in liquid, air or surface environments. | Location Charlotte | |
Company Sanesco International Inc. | Activity: Research and Development | Company Description Sanesco develops clinical tools for healthcare providers, such as neuroendocrine analytical testing, nutritional support formulas and patient-centered clinical review. The NeuroLab division conducts research and development of in vitro diagnostic tools. | Location Arden |